These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11546892)

  • 1. Sulfonylurea drugs do not influence initial stroke severity and in-hospital outcome in stroke patients with diabetes.
    Weih M; Amberger N; Wegener S; Dirnagl U; Reuter T; Einhäupl K
    Stroke; 2001 Sep; 32(9):2029-32. PubMed ID: 11546892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke.
    Kunte H; Schmidt S; Eliasziw M; del Zoppo GJ; Simard JM; Masuhr F; Weih M; Dirnagl U
    Stroke; 2007 Sep; 38(9):2526-30. PubMed ID: 17673715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors related to the initial stroke severity of posterior circulation ischemic stroke.
    Kim SH; Lee JY; Kim DH; Ham JH; Song YK; Lim EJ; Park CI; Chang SJ; Lee SS
    Cerebrovasc Dis; 2013; 36(1):62-8. PubMed ID: 23921172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial.
    Vaccaro O; Masulli M; Bonora E; Del Prato S; Giorda CB; Maggioni AP; Mocarelli P; Nicolucci A; Rivellese AA; Squatrito S; Riccardi G;
    Nutr Metab Cardiovasc Dis; 2012 Nov; 22(11):997-1006. PubMed ID: 23063367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.
    Garratt KN; Brady PA; Hassinger NL; Grill DE; Terzic A; Holmes DR
    J Am Coll Cardiol; 1999 Jan; 33(1):119-24. PubMed ID: 9935017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of admission glucose and diabetes on recanalization and outcome after intra-arterial thrombolysis for ischaemic stroke.
    Arnold M; Mattle S; Galimanis A; Kappeler L; Fischer U; Jung S; De Marchis GM; Gralla J; Mono ML; Brekenfeld C; Meier N; Nedeltchev K; Schroth G; Mattle HP
    Int J Stroke; 2014 Dec; 9(8):985-91. PubMed ID: 22973986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.
    Horsdal HT; Mehnert F; Rungby J; Johnsen SP
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):717-25. PubMed ID: 21536457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarction.
    Halkin A; Roth A; Jonas M; Behar S
    J Thromb Thrombolysis; 2001 Oct; 12(2):177-84. PubMed ID: 11729370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetes mellitus and ischemic cardiopathy: potential effects of the use of sulfonylureas].
    Gonçalves JV; Caldeira J
    Rev Port Cardiol; 2001 Apr; 20(4):439-45. PubMed ID: 11433889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome by stroke etiology in patients receiving thrombolytic treatment: descriptive subtype analysis.
    Mustanoja S; Meretoja A; Putaala J; Viitanen V; Curtze S; Atula S; Artto V; Häppölä O; Kaste M;
    Stroke; 2011 Jan; 42(1):102-6. PubMed ID: 21106955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure and antihypertensive therapy as predictors of early outcome in acute ischemic stroke.
    Keezer MR; Yu AY; Zhu B; Wolfson C; Côté R
    Cerebrovasc Dis; 2008; 25(3):202-8. PubMed ID: 18212508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-hospital stroke recurrence and stroke after transient ischemic attack: frequency and risk factors.
    Erdur H; Scheitz JF; Ebinger M; Rocco A; Grittner U; Meisel A; Rothwell PM; Endres M; Nolte CH
    Stroke; 2015 Apr; 46(4):1031-7. PubMed ID: 25737318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfonylurea use before stroke does not influence outcome.
    Favilla CG; Mullen MT; Ali M; Higgins P; Kasner SE;
    Stroke; 2011 Mar; 42(3):710-5. PubMed ID: 21330623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia is associated with poor outcomes in patients with less severe ischemic stroke.
    Sico JJ; Concato J; Wells CK; Lo AC; Nadeau SE; Williams LS; Peixoto AJ; Gorman M; Boice JL; Bravata DM
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):271-8. PubMed ID: 22100828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of previous diagnosis of diabetes mellitus in the stroke severity and in-hospital outcome in acute cerebral infarction].
    Ortega-Casarrubios MA; Fuentes B; San José B; Martínez P; Díez-Tejedor E
    Neurologia; 2007 Sep; 22(7):426-33. PubMed ID: 17853961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors profile and clinical outcome of ischemic stroke patients admitted in a Department of Internal Medicine and classified by TOAST classification.
    Pinto A; Tuttolomondo A; Di Raimondo D; Fernandez P; Licata G
    Int Angiol; 2006 Sep; 25(3):261-7. PubMed ID: 16878074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated diastolic but not systolic blood pressure increases mortality risk in hypertensive but not normotensive patients with acute ischemic stroke.
    Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Papadopoulou M; Kostaki S; Dourliou V; Papagianni M; Savopoulos C; Hatzitolios AI
    Am J Hypertens; 2015 Jun; 28(6):765-71. PubMed ID: 25468807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction.
    Zeller M; Danchin N; Simon D; Vahanian A; Lorgis L; Cottin Y; Berland J; Gueret P; Wyart P; Deturck R; Tabone X; Machecourt J; Leclercq F; Drouet E; Mulak G; Bataille V; Cambou JP; Ferrieres J; Simon T;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4993-5002. PubMed ID: 20702526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why do acute ischemic stroke patients with a preceding transient ischemic attack present with less severe strokes? Insights from the German Stroke Study.
    Weber R; Diener HC; Weimar C;
    Eur Neurol; 2011; 66(5):265-70. PubMed ID: 21997607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.